CRISPR/Cas9 Screening for Identification of Genes Required for the Growth of Ovarian Clear Cell Carcinoma Cells

被引:0
作者
Kawabata, Ayako [1 ,2 ]
Hayashi, Tomoatsu [1 ]
Akasu-Nagayoshi, Yoko [1 ,2 ]
Yamada, Ai [1 ]
Shimizu, Naomi [1 ]
Yokota, Naoko [3 ]
Nakato, Ryuichiro [3 ]
Shirahige, Katsuhiko [4 ]
Okamoto, Aikou [2 ]
Akiyama, Tetsu [1 ]
机构
[1] Univ Tokyo, Inst Quantitat Biosci, Lab Mol & Genet Informat, Tokyo 1130032, Japan
[2] Jikei Univ, Dept Obstet & Gynecol, Sch Med, Tokyo 1058461, Japan
[3] Univ Tokyo, Inst Quantitat Biosci, Lab Computat Genet, Tokyo 1130032, Japan
[4] Univ Tokyo, Inst Quantitat Biosci, Lab Genome Struct & Funct, Tokyo 1130032, Japan
基金
日本学术振兴会;
关键词
ovarian cancer; ovarian clear cell carcinoma; CRISPR; Cas9; system; proliferation; tumorigenesis; POOR-PROGNOSIS; CANCER; MUTATIONS; ARID1A;
D O I
10.3390/cimb44040108
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Epithelial ovarian cancer is classified into four major histological subtypes: serous, clear cell, endometrioid and mucinous. Ovarian clear cell carcinoma (OCCC) responds poorly to conventional chemotherapies and shows poor prognosis. Thus, there is a need to develop new drugs for the treatment of OCCC. In this study, we performed CRISPR/Cas9 screens against OCCC cell lines and identified candidate genes important for their proliferation. We found that quite different genes are required for the growth of ARID1A and PIK3CA mutant and wild-type OCCC cell lines, respectively. Furthermore, we found that the epigenetic regulator KDM2A and the translation regulator PAIP1 may play important roles in the growth of ARID1A and PIK3CA mutant, but not wild-type, OCCC cells. The results of our CRISPR/Cas9 screening may be useful in elucidating the molecular mechanism of OCCC tumorigenesis and in developing OCCC-targeted drugs.
引用
收藏
页码:1587 / 1596
页数:10
相关论文
共 41 条
[31]   Genome-Wide Interrogation of Human Cancers Identifies EGLN1 Dependency in Clear Cell Ovarian Cancers [J].
Price, Colles ;
Gill, Stanley ;
Ho, Zandra V. ;
Davidson, Shawn M. ;
Merkel, Erin ;
McFarland, James M. ;
Leung, Lisa ;
Tang, Andrew ;
Kost-Alimova, Maria ;
Tsherniak, Aviad ;
Jonas, Oliver ;
Vazquez, Francisca ;
Hahn, William C. .
CANCER RESEARCH, 2019, 79 (10) :2564-2579
[32]   ARID1A Mutations and PI3K/AKT Pathway Alterations in Endometriosis and Endometriosis-Associated Ovarian Carcinomas [J].
Samartzis, Eleftherios P. ;
Noske, Aurelia ;
Dedes, Konstantin J. ;
Fink, Daniel ;
Imesch, Patrick .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (09) :18824-18849
[33]   CSNK1A1, KDM2A, and LTB4R2 Are New Druggable Vulnerabilities in Lung Cancer [J].
Sauta, Elisabetta ;
Reggiani, Francesca ;
Torricelli, Federica ;
Zanetti, Eleonora ;
Tagliavini, Elena ;
Santandrea, Giacomo ;
Gobbi, Giulia ;
Strocchi, Silvia ;
Paci, Massimiliano ;
Damia, Giovanna ;
Bellazzi, Riccardo ;
Ambrosetti, Davide ;
Ciarrocchi, Alessia ;
Sancisi, Valentina .
CANCERS, 2021, 13 (14)
[34]  
Sugiyama T, 2000, CANCER, V88, P2584, DOI 10.1002/1097-0142(20000601)88:11<2584::AID-CNCR22>3.3.CO
[35]  
2-X
[36]   Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging [J].
Takano, M. ;
Kikuchi, Y. ;
Yaegashi, N. ;
Kuzuya, K. ;
Ueki, M. ;
Tsuda, H. ;
Suzuki, M. ;
Kigawa, J. ;
Takeuchi, S. ;
Tsuda, H. ;
Moriya, T. ;
Sugiyama, T. .
BRITISH JOURNAL OF CANCER, 2006, 94 (10) :1369-1374
[37]   Analysis of gene expression signatures identifies prognostic and functionally distinct ovarian clear cell carcinoma subtypes [J].
Tan, Tuan Zea ;
Ye, Jieru ;
Yee, Chung Vin ;
Lim, Diana ;
Ngoi, Natalie Yan Li ;
Tan, David Shao Peng ;
Huang, Ruby Yun-Ju .
EBIOMEDICINE, 2019, 50 :203-210
[38]   Clear cell carcinoma of the ovary: Clinicopathologic features and outcomes in a Chinese cohort [J].
Tang, Haosha ;
Liu, Yan ;
Wang, Xiao ;
Guan, Luyao ;
Chen, Weiming ;
Jiang, Hongyuan ;
Lu, Yuan .
MEDICINE, 2018, 97 (21)
[39]   Integrative analysis of pooled CRISPR genetic screens using MAGeCKFlute [J].
Wang, Binbin ;
Wang, Mei ;
Zhang, Wubing ;
Xiao, Tengfei ;
Chen, Chen-Hao ;
Wu, Alexander ;
Wu, Feizhen ;
Traugh, Nicole ;
Wang, Xiaoqing ;
Li, Ziyi ;
Mei, Shenglin ;
Cui, Yingbo ;
Shi, Sailing ;
Lipp, Jesse Jonathan ;
Hinterndorfer, Matthias ;
Zuber, Johannes ;
Brown, Myles ;
Li, Wei ;
Liu, X. Shirley .
NATURE PROTOCOLS, 2019, 14 (03) :756-780
[40]   Paip1 predicts poor prognosis and promotes tumor progression through AKT/GSK-3β pathway in Lung adenocarcinoma [J].
Wang, Yixuan ;
Piao, Junjie ;
Wang, Qianrong ;
Cui, Xuelian ;
Meng, Ziqi ;
Jin, Tiefeng ;
Lin, Zhenhua .
HUMAN PATHOLOGY, 2019, 86 :233-242